Skip to main content

Day: November 13, 2019

HealthEquity Sets Date to Announce Third Quarter Results Fiscal Year 2020

DRAPER, Utah, Nov. 13, 2019 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), a leading provider of health savings accounts (HSAs) and complementary consumer-directed benefits (“CDBs”), today announced its plans to release financial results for its third quarter of fiscal year 2020, following the close of regular stock market trading hours on Tuesday, December 3, 2019. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, December 3, 2019, at 4:30 p.m. ET during which management will review highlights from the Company’s third quarter and year-to-date fiscal year 2020 results.About HealthEquityHealthEquity administers health savings accounts (HSAs) and other consumer directed benefits for approximately 12 million members in partnership with...

Continue reading

Harrow Health Publishes Third Quarter Letter to Stockholders

NASHVILLE, Tenn., Nov. 13, 2019 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2019.  Please click here to review Harrow Health’s complementary Letter to Stockholders for the third quarter 2019.Mark L. Baum, CEO of Harrow Health, commented, “The third quarter of 2019 brought new records for our core ophthalmology business, as well as record high gross margins and Adjusted EBITDA.  We’ve resolved various legal matters, normalized our cost structure, and completed the restructuring of our pharmaceutical compounding business, which is now sustainably profitable, setting the stage for our march towards our $100 million revenue run rate target in 2021 and 70% gross margins – which should produce about $1 per share of annualized adjusted earnings.  All of these items and more, along...

Continue reading

89bio Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO and HERZLIYA, Israel, Nov. 13, 2019 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the closing of its upsized initial public offering of 6,100,390 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase up to 795,703 additional shares of common stock, at a public offering price of $16.00 per share. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by 89bio, were approximately $97.6 million. All of the shares were offered by 89bio. The shares began trading on The Nasdaq Global Market on November 11, 2019 under...

Continue reading

Autolus Therapeutics to Present at the Jefferies 2019 London Healthcare Conference

LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, today announced that Dr. Christian Itin, chairman and chief executive officer, will present at the Jefferies 2019 London Healthcare Conference on Wednesday, November 20, 2019 at 10:40 am GMT in London, UK.A live webcast of the conference presentation can be access through the investor section of the Autolus website at https://www.autolus.com. A replay will be available following the presentation.About Autolus Therapeutics plcAutolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.  Using a broad suite of proprietary and modular T cell programming...

Continue reading

Investors Community Bank Welcomes New Staff

MANITOWOC, Wis., Nov. 13, 2019 (GLOBE NEWSWIRE) — County Bancorp, Inc. (NASDAQ: ICBK), the parent company for Investors Community Bank (ICB), announced the addition of three new members to its team.Elsa Condon has joined ICB as Vice President – Ag Banking Officer. Condon is primarily based out of the Fond du Lac Loan Production Office, and is responsible for financing of dairy, row crop, beef cattle and diversified farm businesses throughout Wisconsin and the Midwest. She is experienced in working with agricultural businesses who buy from and/or sell to area farms. She also enjoys assisting nonprofit agricultural organizations with their banking needs.Condon holds a Bachelor’s Degree in Agricultural Business from UW-River Falls and is a graduate of the Wisconsin Bankers Association Advanced Ag Lending School. She joins ICB with...

Continue reading

Shaw Says Regulatory Changes Essential to Driving Future Network Investment

CALGARY, Alberta, Nov. 13, 2019 (GLOBE NEWSWIRE) — Shaw Communications Inc. today urged the Federal Cabinet to take steps to ensure Canada has a regulatory environment that delivers affordable internet choices for Canadians and supports the conditions required for continued investment in the backbone of the country’s high-speed internet infrastructure.Shaw and Canada’s other major cable carriers, Rogers, Videotron, Cogeco, and Eastlink, made the request in a petition today asking the Federal Cabinet to require the Canadian Radio-television and Telecommunications Commission (CRTC) to reconsider its August 15, 2019, wholesale internet access rate decision.The CRTC requires cable carriers and telephone companies to provide wholesale access to their networks to reseller internet service providers in order to provide additional retail...

Continue reading

H2O Innovation Announces Election of Board of Directors and Appointment of Auditor

QUEBEC CITY, Nov. 13, 2019 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) held this afternoon its Annual General Meeting of Shareholders (the “Meeting”) at its registered office located in Quebec City, Canada.Shareholders elected or re-elected the following directors to the Corporation’s Board of Directors: Lisa Henthorne, Chairman of the Board of Directors, Richard Hoel, Vice-Chairman of the Board of Directors, Frédéric Dugré, President and Chief Executive Officer, Pierre Côté, René Vachon, Robert Comeau and Stéphane Guérin. Stephen A. Davis left his position on the Board of Directors. Among these seven (7) directors, six (6) are independent.During the Meeting, shareholders appointed Ernst & Young LLP as auditor of the Corporation for the fiscal year ending June 30, 2020. About...

Continue reading

H2O Innovation annonce l’élection de ses administrateurs et la nomination de l’auditeur

QUÉBEC, 13 nov. 2019 (GLOBE NEWSWIRE) — (TSXV : HEO) – H2O Innovation inc. (« H2O Innovation » ou la « Société ») a tenu cet après-midi son assemblée générale annuelle des actionnaires (l’« assemblée ») à son siège social situé à Québec, Canada.Les actionnaires ont élu ou réélu les administrateurs suivants au conseil d’administration de la Société : Lisa Henthorne, présidente du conseil d’administration, Richard Hoel, vice-président du conseil d’administration, Frédéric Dugré, président et chef de la direction, Pierre Côté, René Vachon, Robert Comeau et Stéphane Guérin. Stephen A. Davis quitte ses fonctions au sein du conseil d’administration. Parmi ces sept (7) administrateurs, six (6) sont indépendants.Au cours de l’assemblée, les actionnaires ont désigné la firme Ernst & Young s.e.n.c.r.l./s.r.l. à titre d’auditeur de la...

Continue reading

PDL Community Bancorp Announces Share Repurchase Program

NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) — PDL Community Bancorp (the “Company”) announced today that its Board of Directors has adopted a share repurchase program intended to enhance shareholder value effective November 13, 2019. Under the repurchase program, the Company may repurchase up to 878,835 shares of its common stock, or approximately 5% of the current outstanding shares.The repurchases will be made in accordance with a pre-arranged stock repurchase plan adopted by the Company in accordance with the guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, as well as from time to time through privately negotiated transactions at prevailing market prices, depending on market conditions. Repurchases under the Company’s 10b5-1 plan, administered through an independent broker, are subject to...

Continue reading

Ethan Allen Declares Quarterly Cash Dividend

Danbury, CT, Nov. 13, 2019 (GLOBE NEWSWIRE) — Ethan Allen Interiors Inc. (“Ethan Allen”) (NYSE:ETH) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.21 per share, which will be payable to shareholders of record as of Thursday, January 9, 2020, and will be paid on Thursday, January 23, 2020.Farooq Kathwari, Chairman and CEO commented, “We are pleased to continue our payment of this regular quarterly cash dividend due to the continued strengthening of our enterprise.”ABOUT ETHAN ALLENEthan Allen Interiors Inc. (NYSE: ETH) is a leading interior design company and manufacturer and retailer of quality home furnishings. The Company offers complimentary interior design service to its clients and sells a full range of furniture products and decorative accessories through...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.